Form 4 for ISRG Intuitive Surgical
Accepted 2021-07-26 00:00:00 ET · period of report 2021-07-23 · accession 0001035267-21-000131 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-26 | 2021-07-23 | ISRG | DeSantis Robert | EVP, Chief Product Off | S - Sale+OE | $967.27 | -4,004 | 363 | -92% | -$3.87M |
| DM | 2021-07-26 | 2021-07-23 | ISRG | DeSantis Robert | EVP, Chief Product Off | M - OptEx | $602.79 | +1,389 | 3,461 | +67% | +$837.3K |
| DM | 2021-07-26 | 2021-07-23 | ISRG | DeSantis Robert | EVP, Chief Product Off | M - OptEx | $0.00 | -1,389 | 967 | -59% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-23 | S | D | 422 | $967.23 | 2,978 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $962.83 to $975.41,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2021-07-23 | M | A | 422 | $539.10 | 3,400 | D | — | — | |
| 3 | Common | Common Stock | 2021-07-23 | S | D | 484 | $967.21 | 2,978 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $962.83 to $975.41,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2021-07-23 | M | A | 484 | $727.01 | 3,462 | D | — | — | |
| 5 | Common | Common Stock | 2021-07-23 | M | A | 483 | $533.96 | 3,461 | D | — | — | |
| 6 | Common | Common Stock | 2021-07-23 | S | D | 483 | $967.23 | 2,978 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $962.83 to $975.41,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2021-07-23 | S | D | 2,615 | $967.29 | 363 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $962.83 to $975.41,inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-07-23 | M | D | 484 | $0.00 | 965 | D | $727.01 · — to 2030-08-28 | 484 Common Stock | (F5) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 9 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-07-23 | M | D | 422 | $0.00 | 1,026 | D | $539.10 · — to 2030-05-11 | 422 Common Stock | (F4) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time. |
| 10 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-07-23 | M | D | 483 | $0.00 | 967 | D | $533.96 · — to 2030-02-28 | 483 Common Stock | (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |